Pages that link to "Q47712693"
Jump to navigation
Jump to search
The following pages link to Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease (Q47712693):
Displaying 11 items.
- GH and the cardiovascular system: an update on a topic at heart (Q27002329) (← links)
- Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults. (Q37072338) (← links)
- The pituitary-adrenal axis and body composition (Q37103765) (← links)
- Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas (Q37201576) (← links)
- Psychosomatic aspects of Cushing's syndrome (Q37644244) (← links)
- Adipokines and cardiovascular risk in Cushing's syndrome (Q37953199) (← links)
- Clinical consequences of Cushing's syndrome (Q38004913) (← links)
- Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications (Q38015162) (← links)
- Final adult height and body mass index after cure of paediatric Cushing's disease (Q46419684) (← links)
- Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy. (Q48495807) (← links)
- Remission of Cushing's disease with growth hormone replacement (Q84275988) (← links)